Improving the early markers, such as IL-6, has an impact in reducing cardiovascular risks; furthermore, the implementation of recovery programs for the hypertensive population may prevent complications and the appearance of other pathologies (such as cerebral injuries, coronary accidents or diabetes). This evidence concerns the gene IL6 and diabetes mellitus.